Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Multicenter, prospective, observational study for evaluating if circulant rheumatoid factor,
cyclic citrullinated anti-peptide anti-bodies and albumin can be used as potential predictors
in the response to the treatment with anti-TNF in patients with rheumatoid arthritis after 24
weeks of treatment.
Details
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute